Brighton Jones LLC
CRL icon

Brighton Jones LLC’s Charles River Laboratories CRL Stock Holding History

Brighton Jones LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$279K Buy
945
+10
+1% +$2.64K ﹤0.01% 1099
2026
Q2 		$212K Buy
+935
New +$166K ﹤0.01% 1228
2021
Q3 		– Sell
-775
Closed -$287K – 491
2021
Q2 		$287K Buy
+775
New +$259K 0.01% 357

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Brighton Jones LLC's CRL Position: Q3 2026 in Review

Brighton Jones LLC increased its Charles River Laboratories (CRL) stake by 1.1% in Q3 2026, buying an estimated $2.64K and bringing the position to 945 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Brighton Jones LLC first reported a position in CRL in Q2 2021 and has held it in 3 quarters since. The position peaked at $287K in Q2 2021. 353 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Brighton Jones LLC held 945 shares of Charles River Laboratories worth $279K as of Q3 2026.
  • Brighton Jones LLC bought 10 Charles River Laboratories shares in Q3 2026, an estimated $2.64K.
  • Charles River Laboratories made up ﹤0.01% of Brighton Jones LLC's portfolio in Q3 2026, its #1099 holding.
  • Brighton Jones LLC first reported a position in Charles River Laboratories in Q2 2021 and has held it in 3 quarters since.
  • Brighton Jones LLC's Charles River Laboratories position peaked at $287K in Q2 2021.
  • 353 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Brighton Jones LLC's 13F filing for Q3 2026, filed 3 Nov 2026.